Company record
MiMedx Group, Inc.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about MiMedx Group, Inc..
Warning letters
-
BiologicsMiMedx Group, Inc.
FDA cites MiMedx for marketing placental product AXIOFILL without BLA or IND and for CGMP failures.
High risk